Olanzapine to Help with Side Effects During Gastric Cancer Treatment
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial tests whether a medication called olanzapine can help reduce nausea and loss of appetite in patients receiving chemotherapy before surgery for stomach cancer. The goal is to help you feel better and maintain nutrition during your cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with stomach cancer (gastric adenocarcinoma) confirmed by biopsy
- You are planning to receive chemotherapy followed by surgery, as recommended by your cancer doctor
- You are at least 18 years old and in reasonably good overall health (ECOG score 0–2, meaning you can do light activity or care for yourself)
- You have normal organ function based on recent blood tests (within 30 days)
- You are not pregnant or breastfeeding, and agree to contraception if able to become pregnant
- You do not have an active infection, uncontrolled HIV/AIDS, active hepatitis, or other serious medical conditions that would prevent safe participation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether olanzapine, a medication that can increase appetite, helps prevent severe appetite loss and muscle wasting in patients with ovarian or stomach cancer who are receiving chemotherapy before surgery. The goal is to help patients maintain nutrition and strength during treatment.
This Phase 2 trial tests whether olanzapine can help people with advanced cancer who are losing weight and not eating enough. It looks for improvements in appetite and weight while you receive your first-line palliative cancer treatment.
This trial tests whether the drug olanzapine can help improve appetite and reduce weight loss in people with advanced cancer who are not currently receiving chemotherapy or other anti-cancer treatment. It may be an option if you have lost weight and have little appetite.
This study tests whether a medicine called olanzapine can improve survival in people with advanced cancers of the upper digestive system or lungs. Olanzapine may help with appetite and weight, which are common problems in these cancers.
This trial tests if the drug olanzapine can help improve appetite in people with head and neck cancer who are getting chemotherapy and radiation. It aims to prevent or reduce weight loss during treatment.
This trial tests a new anti-nausea medicine combination for breast cancer patients getting AC chemotherapy, specifically designed for those with diabetes, obesity, or other metabolic issues. It aims to reduce the need for steroids, which can be riskier for these patients.
Hear when a new Gastric Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.